Abstract
The tyrosine kinase receptor Met and its ligand, hepatocyte growth factor (HGF)/scatter factor are involved in the etiology and progression of a number of human cancers. Coexpression of Met and HGF in mesenchymal cells increases the tumorigenic and metastatic potential of the cells. In the studies described here, we used differential display screening to identify changes in gene expression that are initiated by Met/HGF, and that may lead to these phenotypes. We learned that Met/HGF signaling resulted in greatly decreased fibronectin mRNA production in three different human and mouse tumor cell lines; these decreases in fibronectin mRNA were paralleled by decreases in fibronectin protein. We also found a progressive decrease in fibronectin in tumor explants and metastases derived from the Met/HGF transformed cells. The absence of fibronectin expression is a frequent cancer phenotype; our results indicate that decreases in fibronectin correlate with, but are not essential for, MetHGF/SF-mediated tumorigenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
By acceptance of this article, the publisher or recipient acknowledges the right of the U.S. government and its contractors and agents to retain a non-exclusive, royalty-free license in and to any copyright covering this article
By acceptance of this article, the publisher or recipient acknowledges the right of the U.S. government and its contractors and agents to retain a non-exclusive, royalty-free license in and to any copyright covering this article
Rights and permissions
About this article
Cite this article
Taylor, G., Jeffers, M., Webb, C. et al. Decreased fibronectin expression in Met/HGF-mediated tumorigenesis. Oncogene 17, 1179–1183 (1998). https://doi.org/10.1038/sj.onc.1202004
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202004